British Stockpiled Flu Drug May Be Useless
Posted on: Saturday, 1 October 2005, 21:00 CDT
The virus that causes avian influenza in humans appears to be developing resistance to an anti-viral drug the British government has stockpiled.
The Department of Health spent 186 million pounds ($329 million) on 14.6 million courses of Tamiflu, the Times of London reported. If the H5N1 virus becomes resistant to the anti-viral, the Tamiflu would be useless.
About 100 people worldwide have died of avian influenza, mostly in Southeast Asia -- and almost all have worked directly with poultry and had contact with infected birds. Health experts fear if the flu strain mutates so it can be spread person-to-person, the world could face a disaster like the influenza pandemic at the end of World War I.
Because influenza viruses mutate so readily, vaccines are difficult to develop. British authorities hoped the Tamiflu could be used to contain an epidemic until a vaccine was found.
Source: United Press International
Related Articles
- Walmart Pharmacists Prepare and Offer Tamiflu(R) for Oral Suspension for Children and Elderly at More Than 4,000 Locations
- Roche Statement Regarding Tamiflu U.S. Label Revision
- Tamiflu(R) in Ample Supply for Prevention & Treatment of Seasonal Flu
- Roche Opens Full National Distribution for Seasonal Supply of Tamiflu(R)
- Roche Boosts Tamiflu Shipments to States
- Roche Steps Up Tamiflu(R) Distribution in U.S. Cities Reporting Increased Flu Incidence
- U.S. Food and Drug Administration Extends Prophylaxis Indication for Tamiflu(R) to Children Between One to 12 Years of Age
- Roche Prepared to Work With U.S. Government to Supply Tamiflu(R) for Strategic National Stockpile
- Roche Files Supplemental New Drug Application to Extend Prophylaxis Indication for Tamiflu(R) to Patients Between One to 12 Years of Age
- HHS Cites Tamiflu in New Antiviral Guidelines for Preventing, Treating Influenza
 |
 |
User Comments (0)
RSS Feeds